“Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company’s Afirma Gene Expression Classifier for use in thyroid nodule diagnosis. This means that Veracyte’s genomic test is now accessible to...